960 related articles for article (PubMed ID: 24908928)
1. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
Stock I
Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
[TBL] [Abstract][Full Text] [Related]
2. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge.
Nordmann P
Med Mal Infect; 2014 Feb; 44(2):51-6. PubMed ID: 24360201
[TBL] [Abstract][Full Text] [Related]
3. Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns.
Rapp RP; Urban C
Pharmacotherapy; 2012 May; 32(5):399-407. PubMed ID: 22488420
[TBL] [Abstract][Full Text] [Related]
4. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
Tängdén T; Giske CG
J Intern Med; 2015 May; 277(5):501-12. PubMed ID: 25556628
[TBL] [Abstract][Full Text] [Related]
5. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
Livermore DM; Warner M; Mushtaq S; Doumith M; Zhang J; Woodford N
Int J Antimicrob Agents; 2011 May; 37(5):415-9. PubMed ID: 21429716
[TBL] [Abstract][Full Text] [Related]
6. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
Oteo J; Miró E; Pérez-Vázquez M; Navarro F
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
[TBL] [Abstract][Full Text] [Related]
7.
Kazmierczak KM; Bradford PA; Stone GG; de Jonge BLM; Sahm DF
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249690
[No Abstract] [Full Text] [Related]
8. Carbapenemases in Enterobacteriaceae: types and molecular epidemiology.
Martínez-Martínez L; González-López JJ
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():4-9. PubMed ID: 25542046
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes.
Falagas ME; Karageorgopoulos DE; Nordmann P
Future Microbiol; 2011 Jun; 6(6):653-66. PubMed ID: 21707312
[TBL] [Abstract][Full Text] [Related]
10. Carbapenemase-producing Enterobacteriaceae.
Doi Y; Paterson DL
Semin Respir Crit Care Med; 2015 Feb; 36(1):74-84. PubMed ID: 25643272
[TBL] [Abstract][Full Text] [Related]
11. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.
Deshpande P; Rodrigues C; Shetty A; Kapadia F; Hedge A; Soman R
J Assoc Physicians India; 2010 Mar; 58():147-9. PubMed ID: 20848811
[TBL] [Abstract][Full Text] [Related]
12. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe.
Cantón R; Akóva M; Carmeli Y; Giske CG; Glupczynski Y; Gniadkowski M; Livermore DM; Miriagou V; Naas T; Rossolini GM; Samuelsen Ø; Seifert H; Woodford N; Nordmann P;
Clin Microbiol Infect; 2012 May; 18(5):413-31. PubMed ID: 22507109
[TBL] [Abstract][Full Text] [Related]
13. [KPC carbapenemases: what is at stake in clinical microbiology?].
Cuzon G; Naas T; Nordmann P
Pathol Biol (Paris); 2010 Feb; 58(1):39-45. PubMed ID: 19854586
[TBL] [Abstract][Full Text] [Related]
14. Extended-spectrum beta-lactamase-producing organisms.
Falagas ME; Karageorgopoulos DE
J Hosp Infect; 2009 Dec; 73(4):345-54. PubMed ID: 19596491
[TBL] [Abstract][Full Text] [Related]
15. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).
Deshpande LM; Jones RN; Fritsche TR; Sader HS
Microb Drug Resist; 2006; 12(4):223-30. PubMed ID: 17227206
[TBL] [Abstract][Full Text] [Related]
16. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.
Nordmann P; Cuzon G; Naas T
Lancet Infect Dis; 2009 Apr; 9(4):228-36. PubMed ID: 19324295
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.
Jeong SH; Kim HS; Kim JS; Shin DH; Kim HS; Park MJ; Shin S; Hong JS; Lee SS; Song W
Ann Lab Med; 2016 Nov; 36(6):529-35. PubMed ID: 27578505
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compounds.
Pournaras S; Poulou A; Tsakris A
J Antimicrob Chemother; 2010 Jul; 65(7):1319-21. PubMed ID: 20395214
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?
Harris PN; Ferguson JK
Int J Antimicrob Agents; 2012 Oct; 40(4):297-305. PubMed ID: 22824371
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance in Enterobacteriaceae in Brazil: focus on β-lactams and polymyxins.
Sampaio JL; Gales AC
Braz J Microbiol; 2016 Dec; 47 Suppl 1(Suppl 1):31-37. PubMed ID: 27825605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
